OpenAlex
PricingAboutJobs
Log inGet started
Work

P3.13.13 A Phase II Study of Vobramitamab Duocarmazine in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer

HTML

Year: 2025
Type: article
Source: Journal of Thoracic Oncology
DOI: 10.1016/j.jtho.2025.09.949
Authors: T. Roy, J. Zaemes, J. Reuss, V. Yeung, E. Dimeo, J. Thompson, N. Swanson, A. Duttargi, B. Gupta, M. Gonzalez Velez, D. de Miguel Perez, M. Gutierrez, J. Ahn, C. Rolfo, S. Liu, C. Kim
Institutions: Georgetown University, Beth Israel Deaconess Medical Center, Rutgers Cancer Institute, Hackensack University Medical Center, The Ohio State University
Language: English

Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: extensive-stage small cell lung cancer, B7-H3, antibody-drug conjugates, duocarmycin, topoisomerase I inhibitor, immune checkpoint inhibitors, DNA alkylating agents
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W4415519516
FWCI: 0.369
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security